 survival years group children stage IV year age diagnosis cure possible small subgroup objectives study role selection bone marrow transplantation BMT role vincristine melphalan total body irradiation TBI consolidation induction therapy stage IV months diagnosis role immunomagnetic purging metastatic neuroblastoma consecutive unselected patients induction complete remission CR partial remission PR bone marrow progression harvest progression parental refusal Sixty-two patients CR/very good PR VGPR PR excision initial tumor catecholamine secretions minor bone marrow involvement positive bone scan Median observation time months Progression-free survival PFS patients years years PFS grafted population years years years difference patients CR/VGPR PR group children complete normalization metastasis regardless primary-site tumor status group PFS months relapses years group patients bone involvement BMT PFS years bone-positive patients BMT children diagnosis bone involvement Evans stage IVS stage Memphis BMT PFS years late relapses subgroup stage IV neuroblastoma patients year age diagnosis curable therapeutic approach use multivariate analyses prognostic factors international registries